Work

Chemosensitisation of malignant melanoma by BCL2 antisense therapy

Year: 2000

Type: article

Study design: Clinical Trial

Source: The Lancet

DOI: 10.1016/s0140-6736(00)03207-4

Authors: B Jansen, V Wacheck, E Heere-Ress, H Schlagbauer-Wadl, C Hoeller, T Lucas, M Hoermann, U Hollenstein, K Wolff, H Pehamberger

Institutions: University of Vienna, Vienna General Hospital

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Universität Wien

OpenAlex ID: W2113211717

FWCI: 14.93

Cites: 26

Cited by: 481

Related to: 10